Cancer. Breaching the cancer fortress.
Olson
Peter
P
Comprehensive Cancer Center, Diabetes Center and Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143-0534, USA. polson@diabetes.ucsf.edu
Hanahan
Douglas
D
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D021441:Carcinoma, Pancreatic Ductal / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004195:Disease Models, Animal; D005347:Fibroblasts / Q000473:pathology; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic; D010190:Pancreatic Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D015398:Signal Transduction / Q000187:drug effects; D017154:Stromal Cells / Q000187:drug effects / Q000473:pathology; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D053823:Hedgehog Proteins; D003841:Deoxycytidine; D000093542:Gemcitabine